Because c-Myc is overexpressed in many human cancers, such as breast cancer, colon cancer, cervical cancer, small-cell lung carcinomas, osteosarcomas, glioblastomas, melanoma, and myeloid leukaemias22, 23, 24, it is an attractive anti-cancer target. Here, MYC is linked to cancer.